琥珀酸亚铁

琥珀酸亚铁（CAS 10030-90-7）的公开数据库记录，列此仅供独立核对。

物理形态与操作说明

• The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.

这个物质在各数据库里的编号

数据库记载的用途

• Used in preventing and treating iron-deficiency anemia.
• Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.
• B - Blood and blood forming organs
• B03AA - Iron bivalent, oral preparations
• QB - Blood and blood forming organs
• QB03AA - Iron bivalent, oral preparations

它在各数据库里的别名

Ferrous succinate; 10030-90-7; Butanedioic acid, iron(2+) salt (1:1); Ferrlecit 2; FERROMYN; Iron succinate (fe(o4c4h4)); 818ZYK7N91; butanedioic acid, iron (+2) salt; ferrosuccinate; RefChem:921575; 233-082-3; Iron succinate; iron(II) succinate; butanedioate;iron(2+); Succinic acid iron(II) salt;Succinic acid iron(II) salt; UNII-818ZYK7N91

计算机算出的分子描述符

数据库摘要

iron succinate is identified by CAS 10030-90-7, molecular formula C4H4FeO4 and molecular weight 171.95 g/mol. UNII 818ZYK7N91; InChIKey MDXRFOWKIZPNTA-UHFFFAOYSA-L.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。